https://www.linkedin.com/jobs/view/3976364231
Global Lead - Renal Cancer Imaging
We are seeking an experienced Oncology Imaging expert to join the Clinical Development team. The successful candidate will be responsible for design and execution of imaging studies using standard and advanced radiological techniques and analyzing and interpreting data from these studies to advance the development of novel diagnostic and therapeutic radiopharmaceuticals.
The Global Lead - Renal Cancer Imaging will work closely in a matrix organisation with the respective Global Clinical Leads, Global Program Leads, Clinical Operations, Biostatistics and other relevant cross-functional teams to advance Telix Group’s assets towards the clinic. This will be undertaken via a deep working knowledge of advances in imaging in oncology.
Develop and execute on imaging studies to enable the advancement of diagnostic and therapeutic radiopharmaceuticals
Lead development of imaging sections of clinical study documentation and regulatory documents
Lead the design, analysis, review, and quality control of imaging data to ensure accuracy and quality
Oversight of third-party vendors, such as imaging CROs
Collaborate with Global Clinical Leads, Global Program Leads, Biostatistics, Clinical Operations, and other cross-functional colleagues to ensure strategic and effective implementation of novel imaging approaches in clinical studies
Prepare and deliver presentations, proposals, and reports for senior management, partners, and other stakeholders
10+ years of experience in clinical imaging using CT and PET
5+ years of experience in clinical development within the pharmaceutical or biotechnology industry
Strong knowledge of clinical trial design, methodology, and regulatory requirements
Track record of working effectively with imaging CROs and vendor management
Experience in authoring clinical study and regulatory documents
Experience in oncology
- Forums
- ASX - By Stock
- TLX
- Understanding Telix
Understanding Telix, page-1192
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.86 |
Change
0.680(3.55%) |
Mkt cap ! $6.645B |
Open | High | Low | Value | Volume |
$18.93 | $19.86 | $18.75 | $46.49M | 2.405M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1753 | $19.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.86 | 1052 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1753 | 19.840 |
2 | 1125 | 19.730 |
1 | 7685 | 19.690 |
1 | 15241 | 19.670 |
1 | 7685 | 19.660 |
Price($) | Vol. | No. |
---|---|---|
19.860 | 1052 | 1 |
19.870 | 1504 | 1 |
19.880 | 3609 | 3 |
19.890 | 3697 | 2 |
19.900 | 5729 | 2 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |